alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Veljo KURIK, Appellant, v. Aime SAABAS, Ilmar Saabas, Peeter Saabas and Helen Uurman, as successors in interest to Enn Saabas, deceased, Appellees.

No. 4D17-2682

District Court of Appeal of Florida, Fourth District.

April 19, 2018

Seth Wieder of Loan Lawyers, LLC, Fort Lauderdale, for appellant.

Alan B. Gest of Alan B. Gest, P.A., Aventura, for appellees.

Per Curiam.

*Affirmed.*

Damoorgian, Ciklin and Levine, JJ., concur.
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4.

### IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 09-40856 c/w No. 09-40859 Summary Calendar UNITED STATES OF AMERICA, Plaintiff-Appellee v. JOEL MENDOZA-MATA, Defendant-Appellant

Appeals from the United States District Court for the Southern District of Texas USDC No. 1:09-CR-331-1 USDC No. 1:08-CR-1194-1 Before JOLLY, WIENER, and ELROD, Circuit Judges. PER CURIAM: * The Federal PublicDefender appointed to represent Defendant-Appellant Joel Mendoza-Mata has moved for leave to withdraw and has filed a brief in accordance with Anders v. California, 386 U.S. 738 (1967). Mendoza-Mata has not filed a response. Our independent review of the record and counsel’s brief discloses no nonfrivolous issue for appeal. Accordingly, counsel’s motion for United States Court of Appeals

Fifth Circuit 

### F I L E D April 15, 2010 Lyle W. Cayce ClerkNo. 09-40856 c/w No. 09-40859

2 leave towithdrawis GRANTED, counsel isexcused from further responsibilities herein, and the consolidated APPEALS ARE DISMISSED. See 5 TH C IR. R. 42.2.
Arthur GOLDMACHER, Appellant, v. TOWN OF PALM BEACH, a Municipal Corporation of the State of Florida, Appellee.

No. 4D17-2162

District Court of Appeal of Florida, Fourth District.

March 15, 2018

**DECISION WITHOUT PUBLISHED OPINION**

*Affirmed.*
IIB 

111TH CONGRESS 

2D SESSION H. R. 4547 

IN THE SENATE OF THE UNITED STATES 

MARCH 10, 2010 

Received; read twice and referred to the Committee on Homeland Security and 

Governmental Affairs 

AN ACT 

To designate the facility of the United States Postal Service 

located at 119 Station Road in Cheyney, Pennsylvania, 

as the ‘‘Captain Luther H. Smith, U.S. Army Air Forces 

Post Office’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


tjames on DSKG8SOYB1PROD with BILLS
2 

HR 4547 RFS

1 SECTION 1. CAPTAIN LUTHER H. SMITH, U.S. ARMY AIR 

2 FORCES POST OFFICE. 

3 (a) DESIGNATION.—The facility of the United States 

4 Postal Service located at 119 Station Road in Cheyney, 

5 Pennsylvania, shall be known and designated as the ‘‘Cap6 tain Luther H. Smith, U.S. Army Air Forces Post Office’’. 

7 (b) REFERENCES.—Any reference in a law, map, reg8 ulation, document, paper, or other record of the United 

9 States to the facility referred to in subsection (a) shall 

10 be deemed to be a reference to the ‘‘Captain Luther H. 

11 Smith, U.S. Army Air Forces Post Office’’. 

Passed the House of Representatives March 9, 

2010. 

Attest: LORRAINE C. MILLER, 

Clerk. 


tjames on DSKG8SOYB1PROD with BILLS
# COVID-19 Vaccine Appointments Available to All Eligible DOD Beneficiaries

### 19 Apr 2021

DOD beneficiaries and other individuals who are eligible and authorized by the DOD to get a vaccine through the DOD can go to https://www.tricare.mil/vaccineappointments and follow the links to the appropriate location to make an appointment.The DOD is currently providing the Pfizer-BioNTech and Moderna COVID-19 vaccines, the specific brand of vaccine for appointments may vary depending on what the hospital or clinic has available. The FDA and CDC recommend pausing the use of the Janssen vaccine on April 13 after the reports of “rare and severe” blood clots. The Defense Health Agency and the Military Health System immediately implemented their guidance and is not currently administering the Janssen vaccine.Vaccines save lives and the CDC recommends Americans should continue to get vaccinated as soon as possible. The danger of COVID-19 disease outweighs the risk of serious side effects from a vaccine.Safe COVID-19 vaccines were developed through a century of vaccine experience; technology that had been studied for two decades; a prototype coronavirus vaccine already in development at NIH; and tens of thousands of volunteers for clinical trials that enabled rapid accumulation of data on safety and effectiveness. Millions of Americans have already received COVID-19 vaccines, and all COVID-19 vaccines will continue to be intensely monitored for safety.Individuals who still have questions or concerns about the COVID-19 vaccines should speak with their health care provider or can call the TRICARE Nurse Advice Line at 1-800-TRICARE (874-2273), option 1 in the United States or visit www.mhsnurseadviceline.com for country-specific phone numbers outside the United States.The FDA and CDC also have a significant amount of information available to anyone interested in learning more about the COVID19 vaccines.FDA Pfizer-BioNTech COVID-19 vaccine factsheets: https://go.usa.gov/xAmcEFDA Moderna COVID-19 vaccine factsheets: https://go.usa.gov/xAmcVCDC COVID-19 vaccine page: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html
Jon KLEIN, Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-5315

District Court of Appeal of Florida, Second District.

Opinion filed February 14, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Executive Order 12866 

and 

Congressional Review Requirements 

Rulemaking Document TH\ei^h>^^H^^ ^ I ^^i^^c^Oj^^^f^^C^^i ^ ^^ ^^ ^ 

With respect to the attached rulemaking document(s): 

1. E.0.12866: The requirements of section 6(a)(3)(E) of E.O. 12866 have been met in accordance with the 

following [initial appropriate line]; iitiai api 

The rulemaking document(s) was not reviewed by the Office of Information and 

Regulatory Affairs (OIRA). 

No substantive changes were made to the document(s) after it was submitted to OIRA. 

The required information is attached. 

2. Congressional Review: The requirements of the Small Business Regulatory Enforcement Fairness Act 

for the submission of final rules to Congress and GAO(§ 801) have been met in accordance with the 

following [initial appropriate line); 

This document is not a final rule. 

This document is not a rule under (§ 804). 

The document has been submitted to C-50 for transmission to Congress and GAO. 

Signal uri 

Name 

Title/Office 

Date
UNITED STATES DISTRICT COURT

THE SOUTHERN DISTRICT OF OHIO

EASTERN DIVISION

IN RE: DAVOL, INC./C.R. BARD, 

INC., POLYPROPYLENE HERNIA 

MESH PRODUCTS LIABILITY 

LITIGATION

This document relates to: 

Gelfarb v. Johnson & Johnson, et al.

Case No. 2:18-cv-844

Case No. 2:18-md-2846

Judge Edmund A. Sargus, Jr. 

Magistrate Judge Kimberly A. Jolson

ORDER

This matter is before the Court on Plaintiff’s unopposed Motion to Substitute Party. (ECF 

No. 46.) Rule 25 provides that, “[i]f a party dies and the claim is not extinguished, the court may 

order substitution of the proper party.” Fed. R. Civ. P. 25(a)(1). “A motion for substitution may 

be made by any party or by the decedent’s successor or representative.” Id. 

Following Plaintiff’s death, Reuven Gelfarb was appointed as administrator of Plaintiff’s

estate. (ECF No. 46-1.) Plaintiff now moves for the substitution of Reuven Gelfarb, as 

administrator of the estate of Eda Gelfarb, as the proper plaintiff. (ECF No. 46.) Plaintiff’s

unopposed Motion to Substitute is GRANTED. The Clerk is directed to substitute Reuven 

Gelfarb, as administrator of the estate of Eda Gelfarb, as Plaintiff in place of Eda Gelfarb. 

Plaintiff’s initial Motion to Substitute (ECF No. 45) is DENIED AS MOOT.

IT IS SO ORDERED.

6/7/2023 s/Edmund A. Sargus, Jr.

DATE EDMUND A. SARGUS, JR.

UNITED STATES DISTRICT JUDGE

Case: 2:18-cv-00844-EAS-KAJ Doc #: 48 Filed: 06/07/23 Page: 1 of 1 PAGEID #: 462
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<RESTATED>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          FEB-01-1997
<PERIOD-START>                             FEB-04-1996
<PERIOD-END>                               MAY-04-1996
<CASH>                                           7,153
<SECURITIES>                                         0
<RECEIVABLES>                                    4,548
<ALLOWANCES>                                         0
<INVENTORY>                                     42,925
<CURRENT-ASSETS>                                57,130
<PP&E>                                         133,420
<DEPRECIATION>                                  47,790
<TOTAL-ASSETS>                                 146,573
<CURRENT-LIABILITIES>                           33,576
<BONDS>                                         22,226
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        78,819
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   146,573
<SALES>                                         88,135
<TOTAL-REVENUES>                                88,135
<CGS>                                           67,013
<TOTAL-COSTS>                                   67,013
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 613
<INCOME-PRETAX>                                  1,218
<INCOME-TAX>                                       487
<INCOME-CONTINUING>                                731
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       731
<EPS-PRIMARY>                                     0.08
<EPS-DILUTED>                                     0.08
        

</TABLE>
EX PARTE Reginald Anton ANDERS

CR-15-1318

Court of Criminal Appeals of Alabama.

March 6, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Mand. pet. dismissed.
#                         Rear Admiral Christopher Alexander                    

#### Commander, Carrier Strike Group NINE

 Download                            

 Download                                        

Commander, Carrier Strike Group NINE

## Rear Admiral Christopher Alexander

----

-  **                                            Share                                         
-  **                                            PRINT                                         
-  **                                            RSS                                         

Rear Admiral Alexander, a native of Key West, Florida, graduated from the U.S. Naval Academy in 1992 with a Bachelor of Science in Engineering and earned a Master of Science in Operational Research from the Naval Postgraduate School.

At sea, he served as Damage Control Assistant aboard USS Wabash (AOR 5); Navigator aboard USS Reid (FFG 30); Operations Officer aboard USS Arleigh Burke (DDG 51); Operations Officer for Destroyer Squadron 2; and Executive Officer of USS Hopper (DDG 70).

Ashore, Alexander served as the Maritime Operations Center director for U.S. 3rd Fleet; as Executive Assistant for Commander, Naval Surface Force U.S. Pacific Fleet; as a legislative fellow; on the staffs of the Secretary of the Navy and Chief of Naval Operations; and on the Joint Staff.

Alexander commanded USS Sampson (DDG 102), USS Princeton (CG 59), the Surface Warfare Schools Command, and Naval Surface and Mine Warfighting Development Center.

While in command, his Sailors earned Battle “E” Efficiency awards, Spokane Trophies, the Arizona Memorial Trophy, and the James F. Chezek Memorial Gunnery Award.

Alexander assumed the role of Commander, Carrier Strike Group NINE in June 2023.

*Last Updated: 14 July 2023*

----

-  **                                Share                             
-  **                                PRINT                             
-  **                                RSS
Exhibit 10.17


 


November 13, 2008


 


Mark McCamish


[***]


[***]


 


Dear Mark:


 


On behalf of Facet Biotech Corporation, I am pleased to extend to you
an employment offer for the position of Sr. VP &
Chief Medical Officer, reporting to Faheem
Hasnain, President and CEO
effective December 1, 2008.


 


The bi-weekly base salary for this position will be $14,734.62 ($383,100
on an annualized basis) which will be paid in accordance with Facet Biotech’s
payroll procedures.   We offer our
employees an attractive benefits package, including comprehensive medical and
dental plans, and life insurance coverage, in addition to a competitive bonus
program, all of which you will be eligible for in accordance with the terms of
those plans and programs.


 


For purposes of federal immigration law, you are required to provide to
Facet Biotech documentary evidence of your identity and eligibility for
employment in the United States. 
Information related to what type of documentation qualifies is included
in your information packet. You must provide such documentation to us within
three business days of your date of hire.


 


Your employment with Facet Biotech will not be for a set term and you
will at all times be employed as an at-will employee. As an at-will employee
you will be free to resign at any time, just as Facet Biotech will be free to
terminate your employment at any time, with or without cause.  There will be no express or implied
agreements to the contrary.


 


Our offer of employment to you is contingent upon the successful
completion of our background check.  If
Facet does not already have a background check for you, we will perform one.


 


To indicate your acceptance of this offer, please sign and date this
letter in the space provided below and return it to the Human Resources Department,
along with the other required paperwork you received in your information
packet.  This offer letter supersedes any
prior representations or agreements, whether written or oral, with respect to
our offer of employment to you.  This
letter may not be modified or amended except by a written agreement, signed by
Facet Biotech and you.


 

















 


We are very excited at the prospect of your joining Facet Biotech as a
key contributor. This offer will remain open until December 1, 2008, at
which time it will expire if not previously accepted.


 


Sincerely,


 


Facet Biotech


 


 


	
  /s/ Gwen Carscadden  

  	
   

  	
  I accept all of the terms above.

  
	
  Gwen Carscadden

  	
   

  	
   

  
	
  Director of Human Resources

  	
   

  	
  /s/ Mark McCamish

  
	
   

  	
   

  	
  Mark McCamish

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  February 13, 2009

  
	
   

  	
   

  	
  Date
Yancy Charles LIGHTNER, Appellant(s)/Petitioner(s), v. The STATE of Florida, Appellee(s)/Respondent(s),

CASE NO.: 3D17-1966

District Court of Appeal of Florida, Third District.

AUGUST 31, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
## In the Court of Appeals Second Appellate District of Texas

at Fort Worth

___________________________ No. 02

- 22

- 00263

- CV

___________________________

On Appeal from the 158th District Court Denton County, Texas Trial Court No. 22

- 4364

- 158

Before Womack, Wal lach, and Walker, JJ. Per Curiam Memorandum Opinion 

### B ARBARA 

### E LLEN 

### L

YNCH 

### , Appellant

V



### . J ASON 

### P AUL 

### N IELD 

### , Appellee2 MEMORANDUM OPINION AND JUDGMENT
On October 14, 2022, we notified appellant that her brief had not been filed as the appellate rules require. See Tex. R. App. P. 38.6(a). We stated that we could

dismis s the appeal for want of prosecution unless
, on or before October 24, 2022
, appellant filed with the court a n appellant ’ s brief and a n accompanying motion
reasonably explaining the brief’s untimely filing and why an extension was needed. See
Tex. R. App. P. 10.5(b), 38 .8(a)(1), 42.3(b). We have received no response.
Because appellant has failed to file a brief even after we afforded an
opportunity to explain the initial failure, we dismiss the appeal for want of
prosecution. See Tex. R. App. P. 38.8(a)(1 ), 42.3(b), 43 .2(f).
Appellant must pay all costs of this appeal.

Per Curiam

Delivered : November 1 0, 2022
J.C., Appellant/Petitioner(s), v. DEPT. OF CHILDREN & FAMILIES, Appellee/Respondent(s).

CASE NO.: 2D17-4101

District Court of Appeal of Florida, Second District.

March 9, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
IA 

117TH CONGRESS 

1ST SESSION H. J. RES. 32 

Proposing a balanced budget amendment to the Constitution of the United 

States. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 19, 2021 

Mr. OBERNOLTE submitted the following joint resolution; which was referred 

to the Committee on the Judiciary 

JOINT RESOLUTION 

Proposing a balanced budget amendment to the Constitution 

of the United States. 

1 Resolved by the Senate and House of Representatives 

2 of the United States of America in Congress assembled

3 (two-thirds of each House concurring therein), That the fol4 lowing article is proposed as an amendment to the Con5 stitution of the United States, which shall be valid to all 

6 intents and purposes as part of the Constitution when 

7 ratified by the legislatures of three-fourths of the several 

8 States within seven years after the date of its submission 

9 for ratification: 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•HJ 32 IH 

1 ‘‘ARTICLE— 

2 ‘‘SECTION 1. Total outlays for any fiscal year shall 

3 not exceed total receipts for that fiscal year, unless two4 thirds of the whole number of each House of Congress 

5 shall provide by law for a specific excess of outlays over 

6 receipts by a rollcall vote. 

7 ‘‘SECTION 2. Prior to each fiscal year, the President 

8 shall transmit to the Congress a proposed budget for the 

9 United States Government for that fiscal year in which 

10 total outlays do not exceed total receipts. 

11 ‘‘SECTION 3. The Congress shall enforce and imple12 ment this article by appropriate legislation, which may rely 

13 on estimates of outlays and receipts. 

14 ‘‘SECTION 4. Total receipts shall include all receipts 

15 of the United States Government except those derived 

16 from borrowing. Total outlays shall include all outlays of 

17 the United States Government except for those for repay18 ment of debt principal. 

19 ‘‘SECTION 5. This article shall take effect beginning 

20 with the fifth fiscal year beginning after its ratification.’’. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS
Exhibit 32.1



CERTIFICATION UNDER SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002



Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that this periodic report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended, and that information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of California Micro Devices Corporation.



|                    |  |  |  |     |  |                            |  |                                            
|------------------- |  |  |  | --- |  | -------------------------- |  | -------------------------------------------
|                    |  |  | 
|Date: June 14, 2005 |  |  |  | By: |  | /s/    ROBERT V.
DICKINSON
|                    |  |  |  |     |  |                            |  | Robert V. Dickinson Chief Executive Officer
|                    |  |  | 
|Date: June 14, 2005 |  |  |  | By: |  | /s/    R. GREGORY
MILLER  
|                    |  |  |  |     |  |                            |  | R. Gregory Miller Chief Financial Officer  



This certification
accompanies this periodic report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by for purposes of Section 18 of the Securities Exchange Act of 1934, as amended or incorporated by reference into any filing
under the Federal Securities Act of 1933, as amended or the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.
<TABLE> <S> <C>

<ARTICLE>                      5
<CIK>                          0000806613
<NAME>                         GEODYNE ENERGY INCOME LTD PSHP I-E

<S>                            <C>
<PERIOD-TYPE>                  12-MOS
<FISCAL-YEAR-END>              DEC-31-1999
<PERIOD-START>                 JAN-01-1999
<PERIOD-END>                   DEC-31-1999
<CASH>                            891,310
<SECURITIES>                            0
<RECEIVABLES>                     772,416
<ALLOWANCES>                            0
<INVENTORY>                             0
<CURRENT-ASSETS>                1,663,726
<PP&E>                         26,692,096
<DEPRECIATION>                 23,118,865
<TOTAL-ASSETS>                  5,859,238
<CURRENT-LIABILITIES>             278,771
<BONDS>                                 0
<PREFERRED-MANDATORY>                   0
<PREFERRED>                             0
<COMMON>                                0
<OTHER-SE>                      5,390,503
<TOTAL-LIABILITY-AND-EQUITY>    5,859,238
<SALES>                         4,161,530
<TOTAL-REVENUES>                4,856,176
<CGS>                                   0
<TOTAL-COSTS>                   2,326,774
<OTHER-EXPENSES>                        0
<LOSS-PROVISION>                        0
<INTEREST-EXPENSE>                      0
<INCOME-PRETAX>                 2,529,402
<INCOME-TAX>                            0
<INCOME-CONTINUING>             2,529,402
<DISCONTINUED>                          0
<EXTRAORDINARY>                         0
<CHANGES>                               0
<NET-INCOME>                    2,529,402
<EPS-BASIC>                         49.27
<EPS-DILUTED>                           0



</TABLE>
EXHIBIT 32.2

                               CERTIFICATION UNDER
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly  Report of Glacier Water  Services,  Inc., (the
Company) on Form 10-Q for the quarter ended September 26, 2004 as filed with the
Securities and Exchange  Commission on the date hereof (the Report), I, W. David
Walters,  Senior Vice  President  and Chief  Financial  Officer of the  Company,
certify,  pursuant to and for the  purposes of 18 U.S.C.  ss.  1350,  as adopted
pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

          (1)  The Report fully complies with the requirements of section 13(a)
               or 15(d) of the Securities Exchange Act of 1934; and

          (2)  The information contained in the Report fairly presents, in all
               material respects, the financial condition of the Company as of
               the dates indicated and results of operations of the Company for
               the periods indicated.


/s/ W. David Walters
-------------------------------------------------

W. David Walters
Senior Vice President and Chief Financial Officer
October 27, 2004